SCHEMBL6636264

SCHEMBL6636264

O=C1C=CC2C(=O)C3C=CC=CC3=C2C1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.30
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003683 0.66
SCHEMBL8621745 0.62 GSK3A (0.32) GSK3AGSK3B
SCHEMBL7426675 0.61 GSK3A (0.31) GSK3AGSK3B
SCHEMBL18797843 0.61
SCHEMBL11646982 0.57
SCHEMBL19472118 0.53 NQO1 (0.33)
SCHEMBL10372116 0.53 NQO1 (0.31)
Carbon Monoxide SCHEMBL5588303 0.52 GSK3A (0.59) GSK3AGSK3B
SCHEMBL6689962 0.51
SCHEMBL12336961 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397361-A1 CARBOLINE DERIVATIVES AS PDEV INHIBITORS Lilly Icos LLC (US) 2004-03-17 EP disclosed
EP-1313736-A2 CONDENSED PYRAZINDIONE DERIVATIVES Lilly Icos LLC (US) 2003-05-28 EP disclosed
WO-2003000691-A1 CARBOLINE DERIVATIVES AS PDEV INHIBITORS LILLY ICOS LLC (US) 2003-01-03 WO disclosed
WO-2002000657-A2 CONDENSED PYRAZINDIONE DERIVATIVES LILLY ICOS LLC (US) 2002-01-03 WO disclosed